title: Do phase 1 patients have greater needs for palliative care compared with other cancer patients?
abstract: BACKGROUND
  Phase 1 oncology trial participants often are excluded from hospice. However, it is not known whether they would benefit from hospice services. The objectives of the current study were to define the palliative care needs of these patients and to determine whether their needs are greater than those of other cancer patients.
  
  
  METHODS
  Two hundred ninety-seven patients who were undergoing cancer therapy and 69 patients who were enrolled in phase 1 trials at 7 oncology clinics in an urban cancer network were recruited and consented to participate in interviews. Interviewers assessed the prevalence and severity of 10 symptoms using the Global Distress Index of the Memorial Symptom Assessment Scale and patients' perceived need for 4 services typically provided through hospice: a chaplain, counselor, home health aide, and visiting nurse.
  
  
  RESULTS
  Patients in the 2 groups had a similar symptom burden. However, after adjusting for Eastern Cooperative Oncology Group performance status scores, phase 1 patients were more likely to have 5 of the 10 symptoms and reported greater severity for 6 of the 10 symptoms. Compared with other patients, phase 1 patients were less likely to say they needed a home health aide (4 of 69 patients [6%] vs 198 of 297 patients [67%]), a chaplain (7 of 69 patients [10%] vs 134 of 297 patients [45%]), or a counselor (11 of 69 patients [16%] vs 160 of 297 patients [54%]; chi-square test: P<.001 for all). They were equally likely to say they needed a visiting nurse (30 of 69 patients [44%] vs 142 of 297 patients [48%]; chi-square test: P=.516).
  
  
  CONCLUSIONS
  Compared with other patients who had cancer, patients who were participating in phase 1 trials were less likely to want several home care services, although they experienced a greater symptom burden. Further research will be needed to define the palliative care needs of this population.
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
authors.forename: Esmé
authors.initials: E
authors.lastname: Finlay
authors.forename: Hien L
authors.initials: HL
authors.lastname: Lu
authors.forename: Hope R
authors.initials: HR
authors.lastname: Henderson
authors.forename: Hope
authors.initials: H
authors.lastname: Henderson
authors.forename: Peter J
authors.initials: PJ
authors.lastname: O'Dwyer
authors.forename: David J
authors.initials: DJ
authors.lastname: Casarett
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002604:Chaplaincy Service, Hospital; D017321:Clinical Trials, Phase I as Topic; D003152:Community Health Nursing; D003376:Counseling; D005260:Female; D006301:Health Services Needs and Demand; D006699:Home Care Services; D017051:Hospice Care; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000628:therapy*; D010166:Palliative Care; D010358:Patient Participation; D012720:Severity of Illness Index